Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Effect of hypoglycemic drugs on aspirin resistance in patients with diabetes mellitus.

Ariturk Z, Islamoglu Y, Gündüz E, Yavuz C, Cil H, Tekbas E, Soydinc S, Kaya H, Elbey MA.

Eur Rev Med Pharmacol Sci. 2012 May;16(5):617-21.

PMID:
22774402
2.

Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management.

Cuisset T, Quilici J, Fugon L, Cohen W, Roux P, Gaborit B, Molines L, Fourcade L, Bonnet JL, Carrieri P.

Arch Cardiovasc Dis. 2011 May;104(5):306-12. doi: 10.1016/j.acvd.2011.03.091. Epub 2011 May 31.

3.

Antiplatelet effect of aspirin in patients with coronary artery disease.

Grove EL.

Dan Med J. 2012 Sep;59(9):B4506. Review.

PMID:
22951204
4.

Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.

van Werkum JW, Topcu Y, Postma S, Kelder JC, Hackeng CM, ten Berg JM, Verheugt FW.

Thromb Haemost. 2008 Mar;99(3):637-9. doi: 10.1160/TH07-07-0465. No abstract available.

PMID:
18327417
5.

Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.

Angiolillo DJ, Bernardo E, Ramírez C, Costa MA, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Bass TA, Macaya C, Fernandez-Ortiz A.

J Am Coll Cardiol. 2006 Jul 18;48(2):298-304. Epub 2006 Jun 22.

6.

Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.

Würtz M, Grove EL, Wulff LN, Kaltoft AK, Tilsted HH, Jensen LO, Hvas AM, Kristensen SD.

JACC Cardiovasc Interv. 2010 Aug;3(8):828-35. doi: 10.1016/j.jcin.2010.05.014.

7.

Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease.

Dillinger JG, Drissa A, Sideris G, Bal dit Sollier C, Voicu S, Manzo Silberman S, Logeart D, Drouet L, Henry P.

Am Heart J. 2012 Oct;164(4):600-606.e1. doi: 10.1016/j.ahj.2012.06.008.

PMID:
23067920
8.
9.

Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus.

Mortensen SB, Larsen SB, Grove EL, Kristensen SD, Hvas AM.

Thromb Res. 2010 Oct;126(4):e318-22. doi: 10.1016/j.thromres.2010.03.013. Epub 2010 May 7.

PMID:
20451957
10.

Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.

Gao F, Wang ZX, Men JL, Ren J, Wei MX.

Chin Med J (Engl). 2011 Jun;124(11):1731-4.

PMID:
21740787
11.

A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.

Wenaweser P, Eshtehardi P, Abrecht L, Zwahlen M, Schmidlin K, Windecker S, Meier B, Haeberli A, Hess OM.

Thromb Haemost. 2010 Sep;104(3):554-62. doi: 10.1160/TH09-11-0765. Epub 2010 Jul 20.

PMID:
20664903
12.

Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.

Duzenli MA, Ozdemir K, Aygul N, Soylu A, Tokac M.

Am J Cardiol. 2008 Aug 15;102(4):396-400. doi: 10.1016/j.amjcard.2008.03.074. Epub 2008 May 22.

PMID:
18678294
13.

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.

Diabetes. 2005 Aug;54(8):2430-5.

14.

Effects of persistent platelet reactivity despite aspirin therapy on cardiac troponin I and creatine kinase-MB levels after elective percutaneous coronary interventions.

Gulmez O, Yildirir A, Kaynar G, Konas D, Aydinalp A, Ertan C, Ozin B, Muderrisoglu H.

J Thromb Thrombolysis. 2008 Jun;25(3):239-46. Epub 2007 Jun 16.

PMID:
17574519
15.

Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.

Kammerer I, Bach J, Saggau W, Isgro F.

Thorac Cardiovasc Surg. 2011 Oct;59(7):425-9. doi: 10.1055/s-0030-1270711. Epub 2011 Mar 24.

PMID:
21437867
16.

A study of aspirin resistance in type 2 diabetes.

Singla MK, Lahiri P, Mukhopadhyay P, Pandit K, Chaudhuri U, Chowdhury S.

J Indian Med Assoc. 2008 Nov;106(11):720, 722-3, 740.

PMID:
19368097
17.

Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.

Sibbing D, Schulz S, Braun S, Morath T, Stegherr J, Mehilli J, Schömig A, von Beckerath N, Kastrati A.

J Thromb Haemost. 2010 Feb;8(2):250-6. doi: 10.1111/j.1538-7836.2009.03709.x. Epub 2009 Nov 28.

18.

Multiple electrode aggregometry predicts stent thrombosis better than the vasodilator-stimulated phosphoprotein phosphorylation assay.

Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B.

J Thromb Haemost. 2010 Feb;8(2):351-9. doi: 10.1111/j.1538-7836.2009.03699.x. Epub 2009 Nov 23.

19.

Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study.

Valgimigli M, Campo G, de Cesare N, Meliga E, Vranckx P, Furgieri A, Angiolillo DJ, Sabatè M, Hamon M, Repetto A, Colangelo S, Brugaletta S, Parrinello G, Percoco G, Ferrari R; Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R) Investigators..

Circulation. 2009 Jun 30;119(25):3215-22. doi: 10.1161/CIRCULATIONAHA.108.833236. Epub 2009 Jun 15.

20.

Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.

Pamukcu B, Oflaz H, Onur I, Oncul A, Umman B, Koylan N, Bugra Z, Meric M, Nisanci Y.

Blood Coagul Fibrinolysis. 2007 Jul;18(5):461-5.

PMID:
17581321

Supplemental Content

Support Center